|
Cut the Cost of Doing Business |
|
SoCalBio partners with Office Depot to offer member companies up to 75% off the manufacturer's suggested retail price on a "core list" of office supplies along with aggressive pricing on other catalog items and furniture ... Learn more
|
|
Thanks to SoCalBio Weekly Update Sponsor
|
|
New SoCalBio Member |
|
With 1000 Lawyers in 12 offices across the US, Asia and Europe, WilmerHale offers legal services to public and private companies, start-up enterprises, partnerships, and entrepreneurial ventures in a wide variety of industrial sectors including the bioscience industry .... Learn more
|
Recommended Events
Save Money on These Events If You Are a SoCalBio Member
September 7 - 9
Boston, MA
September 26- 28
Washington DC
October 3-5
Pasadena, CA
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
When you join, you will enjoy significant discounts on products and services from lab and office supplies to insurance and scientific publications. Discounts are exclusive to SoCalBio member companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino counties... Click here to see why |
 |
| Thanks to SoCalBio Media Partners
| | |
 |
 |
| Regulatory |
|
FDA Accord With Drugmakers Raises User Fees 6% to Renew Law
The increase is expected to add $40.4 million to user-fee revenue in fiscal 2012, bringing the fiscal 2013 total to $712.8 million, Karen Riley, a spokeswoman for the FDA, said in an e- mail. The agency in turn will have to meet with companies in the midst of reviews to raise concerns and ensure that evaluations are carried out in a timely way... Read more
FDA May Classify Surgical Mesh Devices for Failing Organs as High Risk
Makers of surgical mesh may have to submit added safety data to regulators to keep their products on the market under a Food and Drug Administration staff recommendation ... Read more |
| New Companies |
|
Patrick Soon-Shiong Announces Formation of NantWorks, LLC
 Company Will Combine Advanced Communications and Computing Technologies in "Silicon Beach" to Benefit Healthcare, Science, Justice System, Media and Entertainment. Dr. Soon-Shiong, who is a medical scientist and an inventor as well as a physician and surgeon, said his interest in digital technology stems from his conviction that it is the key to the future of healthcare ... Read more
|
Grants
|
|
NeuroSigma Receives Notice of Award from NIH for an STTR Grant for its Trigeminal Nerve Stimulation Therapy for Epilepsy
The grant will support further development of external trigeminal nerve stimulation (eTNS) therapy for the treatment of drug-resistant epilepsy, for which the Los Angeles-base NeuroSigma is the exclusive worldwide licensee of intellectual property developed by the University of California, Los Angeles (UCLA)... Read more |
| Clinical Studies |
|
ImmunoCellular Therapeutics gives Site Update for Phase II trial of ICT-107
 "We are pleased with the progress we have made in our Phase II trial for the treatment of glioblastoma multiforme, said Manish Singh, Ph.D., President and CEO of ImmunoCellular Therapeutics. "We are encouraged by the strong interest we have received from the medical community, and the role that leading oncologists are playing in supporting our efforts to enroll patients" ... Read more
Endologix Receives IDE Approval for the Ventana(TM) Fenestrated Stent Graft System
Endologix announced that it has received Investigational Device Exemption ("IDE") conditional approval from the United States Food and Drug Administration ("FDA") to begin U.S. clinical trials to evaluate the Ventana Fenestrated Stent Graft System for the endovascular repair of juxtarenal and pararenal aortic aneurysms. Endologix expects to begin enrolling patients at a few centers in the U.S. before the end of this year... Read more |
| Patent Litigation |
|
Impax Labs challenges patent on Avanir's Nuedexta
Impax Laboratories Inc. said Wednesday it is challenging the patents on Avanir Pharmaceuticals Inc.'s drug Nuedexta, and it said Avanir has filed a patent infringement lawsuit. Avanir began selling Nuedexta in February. The drug is approved as a treatment for pseudobulbar affect, a condition that involves involuntary emotional outbursts like laughing or crying ... Read more |
Jobs Available
|
|
Freedom Innovations (Irvine)
Anchen Pharmaceuticals (Irvine)
Bioness (Valencia)
Alfred Mann Foundation (Valencia)
Biolase (Irvine)
Radient Pharmaceuticals (Tustin)
Gilead (San Dimas)
| |
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio | | |
